Latest news about Alafair Biosciences
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Alafair Biosciences has surpassed 22,000 patient implants of its VersaWrap Hydrogel Sheet, marking a significant milestone in the company's growth. This achievement highlights the product's growing market adoption and its positive impact on patient outcomes by facilitating tissue gliding and preventing tethering, thus reducing the need for reoperations[1][4].
Alafair Biosciences was awarded a national group purchasing agreement with Premier, Inc. for its VersaWrap Hydrogel Sheet, effective July 1, 2024, allowing Premier members to access special pricing and terms, and further expanding the product's reach to clinicians and patients nationwide[1].
Alafair Biosciences has been selected to exhibit its VersaWrap Hydrogel Sheet at the Vizient Innovative Technology Exchange for the second consecutive year, following an Innovative Technology contract award from Vizient in April 2024, highlighting the product's impact on improving patient outcomes and healthcare delivery[2].
Open job positions at Alafair Biosciences
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

